A New Score to Assess the Perioperative Period of the Cancer Patient Undergoing Non-Palliative Elective Surgery: A Retrospective Evaluation of a Case Report by PERIDIA Score.

ICU anesthesiology cancer patients peridiaphragmatic surgery perioperative score

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2021
Historique:
received: 30 06 2021
accepted: 16 09 2021
entrez: 12 11 2021
pubmed: 13 11 2021
medline: 13 11 2021
Statut: epublish

Résumé

The complexity of cancer patients and the use of advanced and demolitive surgical techniques frequently need post-operatory ICU hospitalization. To increase safety and to select the best medical strategies for the patient, a multidisciplinary team has performed a new peri-operatory assessment, arising from evidence-based literature data. Verifying that most of the cancer patients, admitted to the intensive care unit, undergo major surgery with localizations in the supramesocolic thoraco-abdominal area, the team focused the attention on supramesocolic peridiaphragmatic cancer surgery. Some scores already in use in clinical practice were selected for the peri-operatory evaluation process. None of them evaluate parameters relating to the entire peri-operative period. In detail, only a few study models were found that concern the assessment of the intra-operative period. Therefore, we wanted to see if using a mix of validated scores, it was possible to build a single evaluation score (named PERIDIAphragmatic surgery score or PERIDIA-score) for the entire peri-operative period that could be obtained at the end of the patient's hospitalization period in post-operative ICU. The main property sought with the creation of the PERIDIA-score is the proportionality between the score and the incidence of injuries, deaths, and the length of stay in the ward. This property could organize a tailor-made therapeutic path for the patient based on pre-rehabilitation, physiotherapy, activation of social assistance services, targeted counseling, collaborations with the continuity of care network. Furthermore, if the pre-operative score is particularly high, it could suggest different or less invasive therapeutic options, and if the intra-operative score is particularly high, it could suggest a prolongation of hospitalization in ICU. The retrospective prospective study conducted on 83 patients is still ongoing. The first data would seem to prove an increase of clinical complications in patients who were assigned a one-third score with respect to the maximum (16/48) of PERIDIA-score. Moreover, patients with a 10/16 score within each phase of the evaluation (pre, peri, and post) more frequently develop injuries. In the light of these evidence, the 29-point score assigned to our patient can be considered as predictive for the subsequent critical and fatal complications the patient faced up.

Identifiants

pubmed: 34765547
doi: 10.3389/fonc.2021.733621
pmc: PMC8577042
doi:

Types de publication

Journal Article

Langues

eng

Pagination

733621

Informations de copyright

Copyright © 2021 Andresciani, Calabrò, Laforgia, Ronchi, De Summa, Cariddi, Boccuzzi, De Rosa, Rizzo, Losito, Bradascio, Napoli, Simone, Carravetta and Mastrandrea.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

World J Emerg Surg. 2015 Dec 16;10:61
pubmed: 26677396
Am J Med. 2005 Oct;118(10):1134-41
pubmed: 16194645
Clin Pharmacokinet. 1988 Oct;15(4):227-44
pubmed: 3056649
J Gastrointest Surg. 2020 Oct;24(10):2259-2268
pubmed: 31468333
Medicine (Baltimore). 2016 Feb;95(7):e2724
pubmed: 26886613
Intensive Care Med. 2017 Feb;43(2):192-199
pubmed: 27812731
Int J Surg. 2018 Dec;60:67-73
pubmed: 30399450
Clin Pharmacol Ther. 1989 Dec;46(6):668-73
pubmed: 2513160
Surg Today. 2016 Jun;46(6):668-85
pubmed: 26289837
Br J Anaesth. 2017 Oct 1;119(4):655-663
pubmed: 29121283
JAMA. 1983 May 27;249(20):2808-10
pubmed: 6842789
Ann Intensive Care. 2019 Sep 30;9(1):108
pubmed: 31565779
BMC Geriatr. 2017 Jan 4;17(1):2
pubmed: 28049443
Curr Opin Anaesthesiol. 2014 Jun;27(3):330-5
pubmed: 24566452
Expert Rev Gastroenterol Hepatol. 2017 Jul;11(7):663-672
pubmed: 28454509
J Cardiothorac Vasc Anesth. 2018 Dec;32(6):2665-2672
pubmed: 29709437
N Engl J Med. 1975 Sep 18;293(12):612-3
pubmed: 1152903
Oncol Lett. 2018 Aug;16(2):2023-2029
pubmed: 30008896
Surgery. 2012 Sep;152(3 Suppl 1):S120-7
pubmed: 22766367
Medicine (Baltimore). 2016 Feb;95(8):e2877
pubmed: 26937922
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):547-550
pubmed: 29424916
Int J Surg. 2017 Mar;39:169-175
pubmed: 28161529
Eur J Cardiothorac Surg. 2018 Jan 1;53(1):235-240
pubmed: 29106506
World J Gastroenterol. 2014 Oct 14;20(38):13692-704
pubmed: 25320507
J Clin Pharmacol. 1982 Apr;22(4):201-5
pubmed: 7096606
Clin Pharmacol Ther. 1977 Oct;22(4):389-94
pubmed: 902451
Medicine (Baltimore). 2015 May;94(17):e812
pubmed: 25929938

Auteurs

Letizia Andresciani (L)

DETO Dipartimento di Emergenze e Trapianti d'Organo, Università degli Studi di Bari, Bari, Italy.

Concetta Calabrò (C)

Unità Operativa Complessa Farmacia e UMACA, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Mariarita Laforgia (M)

Unità Operativa Complessa Farmacia e UMACA, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Maria Ronchi (M)

Unità Operativa Complessa Chirurgia Generale Oncologica, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Simona De Summa (S)

Diagnostica Molecolare e Farmacogenetica, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Christel Cariddi (C)

DETO Dipartimento di Emergenze e Trapianti d'Organo, Università degli Studi di Bari, Bari, Italy.

Rosa Boccuzzi (R)

Unità Operativa Complessa Anestesia, Rianimazione e Terapia Intensiva PostOperatoria, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Anna De Rosa (A)

Unità Operativa Complessa Anestesia, Rianimazione e Terapia Intensiva PostOperatoria, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Elisabetta Rizzo (E)

Unità Operativa Complessa Anestesia, Rianimazione e Terapia Intensiva PostOperatoria, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Giulia Losito (G)

Unità Operativa Complessa Anestesia, Rianimazione e Terapia Intensiva PostOperatoria, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Grazia Bradascio (G)

Unità Operativa Complessa Anestesia, Rianimazione e Terapia Intensiva PostOperatoria, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Gaetano Napoli (G)

Unità Operativa Complessa Chirurgia Toracica, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Michele Simone (M)

Unità Operativa Complessa Chirurgia Generale Oncologica, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Giuseppe Carravetta (G)

Unità Operativa Complessa Anestesia, Rianimazione e Terapia Intensiva PostOperatoria, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Giovanni Mastrandrea (G)

Unità Operativa Complessa Anestesia, Rianimazione e Terapia Intensiva PostOperatoria, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II-Bari, Bari, Italy.

Classifications MeSH